Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2026
ICER releases draft evidence report on treatment for narcolepsy
12 March 2026 - Public comment period now open until 7 April 2026; requests to make oral comment during public ...
Posted by Michael Wonder on 12 Feb 2026
ICER publishes final evidence report on medication for smoking cessation
12 February 2026 - Independent appraisal committee votes reflect a net health benefit for cytisinicline alone, but uncertainty when compared ...
Posted by Michael Wonder on 16 Dec 2025
ICER publishes final evidence report on treatments for obesity
16 December 2025 - Independent committee voted unanimously on the positive net health benefit of all three treatments; final report ...
Posted by Michael Wonder on 11 Dec 2025
ICER publishes evidence report on medication for smoking cessation
11 December 2025 - Cytisinicline is effective for smoking cessation; a 12 week course of cytisinicline would be cost effective ...
Posted by Michael Wonder on 11 Dec 2025
ICER releases draft evidence report on therapies for IgA nephropathy
10 December 2025 - Public comment period now open until 14 January 2026; Requests to make oral comment during public ...
Posted by Michael Wonder on 31 Oct 2025
ICER publishes final evidence report on treatment for non-cystic fibrosis bronchiectasis
30 October 2025 - Independent appraisal committee voted unanimously on the positive net health benefit of brensocatib; but current pricing ...
Posted by Michael Wonder on 29 Oct 2025
ICER publishes evidence report on treatments for obesity
29 October 2025 - All three drugs result in substantial weight loss; the therapies are cost effective, but the very ...
Posted by Michael Wonder on 20 Oct 2025
ICER releases draft evidence report on treatment for smoking cessation
20 October 2025 - Public comment period now open until 17 November 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 09 Sep 2025
ICER releases draft evidence report on treatments for obesity
9 September 2025 - Public comment period now open until 6 October 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 09 Sep 2025
ICER publishes evidence report on treatment for non-cystic fibrosis bronchiectasis
8 September 2025 - There are significant uncertainties regarding long term efficacy of brensocatib; ICER estimates that treatment would achieve ...
Posted by Michael Wonder on 23 Jul 2025
ICER releases draft evidence report on treatment for non-cystic fibrosis bronchiectasis
23 July 2025 - Public comment period now open until 19 August 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 29 May 2025
ICER publishes evidence report on treatment for secondary progressive multiple sclerosis
29 May 2025 - There are significant uncertainties regarding long term efficacy of tolebrutinib; ICER estimates that treatment would achieve ...
Posted by Michael Wonder on 27 Mar 2025
ICER publishes evidence report on treatment for retinitis pigmentosa
26 March 2025 - There are significant uncertainties regarding long term efficacy and durability of sonpiretigene isteparvovec; ICER estimates that ...
Posted by Michael Wonder on 10 Feb 2025
ICER releases draft evidence report on treatment for advanced retinitis pigmentosa
6 February 2025 - Public comment period now open until 6 March 2025; requests to make oral comment during public ...
Posted by Michael Wonder on 10 Feb 2025
ICER publishes evidence report on treatment for acute pain
5 February 2025 - Current evidence suggests that suzetrigine may provide a net health benefit when compared to no systemic ...